Metaplanet: Q2 gross profit reaches 816 million yen (5.5 million USD), up 38% quarter-on-quarter
Foresight News reports that the publicly listed company Metaplanet has posted its second quarter financial results: revenue reached 1.239 billion yen (8.4 million USD), up 41% quarter-on-quarter; gross profit was 816 million yen (5.5 million USD), up 38% quarter-on-quarter; operating profit was 17.4 billion yen (117.8 million USD), compared to -6.9 billion yen in the same period last year; net profit was 11.1 billion yen (75.1 million USD), compared to -5.0 billion yen in the same period last year; total assets stood at 238.2 billion yen (1.61 billion USD), up 333% quarter-on-quarter. Net assets were 201.0 billion yen (1.36 billion USD), up 299% quarter-on-quarter.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks
BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Crypto prices
More
